Skip to main content
Top
Published in: Journal of Orthopaedic Surgery and Research 1/2024

Open Access 01-12-2024 | Osteoarthrosis | Research article

PDK4 inhibits osteoarthritis progression by activating the PPAR pathway

Authors: Zhengnan Li, Lifeng Xie, Hui Zeng, Yaohong Wu

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2024

Login to get access

Abstract

Background

Osteoarthritis (OA) is a degenerative joint disease caused by the deterioration of cartilage. However, the underlying mechanisms of OA pathogenesis remain elusive.

Methods

Hub genes were screened by bioinformatics analysis based on the GSE114007 and GSE169077 datasets. The Sprague–Dawley (SD) rat model of OA was constructed by intra-articular injection of a mixture of papain and L-cysteine. Hematoxylin–eosin (HE) staining was used to detect pathological changes in OA rat models. Inflammatory cytokine levels in serum were measured employing the enzyme-linked immunosorbent assay (ELISA). The reverse transcription quantitative PCR (RT-qPCR) was implemented to assess the hub gene expressions in OA rat models. The roles of PDK4 and the mechanism regulating the PPAR pathway were evaluated through western blot, cell counting kit-8 (CCK-8), ELISA, and flow cytometry assays in C28/I2 chondrocytes induced by IL-1β.

Results

Six hub genes were identified, of which COL1A1, POSTN, FAP, and CDH11 expressions were elevated, while PDK4 and ANGPTL4 were reduced in OA. Overexpression of PDK4 inhibited apoptosis, inflammatory cytokine levels (TNF-α, IL-8, and IL-6), and extracellular matrix (ECM) degradation protein expressions (MMP-3, MMP-13, and ADAMTS-4) in IL-1β-induced chondrocytes. Further investigation revealed that PDK4 promoted the expression of PPAR signaling pathway-related proteins: PPARA, PPARD, and ACSL1. Additionally, GW9662, an inhibitor of the PPAR pathway, significantly counteracted the inhibitory effect of PDK4 overexpression on IL-1β-induced chondrocytes.

Conclusion

PDK4 inhibits OA development by activating the PPAR pathway, which provides new insights into the OA management.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ebell MH. Osteoarthritis: rapid evidence review. Am Fam Physician. 2018;97(8):523–6.PubMed Ebell MH. Osteoarthritis: rapid evidence review. Am Fam Physician. 2018;97(8):523–6.PubMed
2.
go back to reference Hawker G. (2019) Osteoarthritis is a serious disease. Clin Exp Rheumatol. 2019;37:3–6.PubMed Hawker G. (2019) Osteoarthritis is a serious disease. Clin Exp Rheumatol. 2019;37:3–6.PubMed
12.
14.
go back to reference Thoudam T, Ha CM, Leem J, Chanda D, Park JS, Kim HJ, Jeon JH, Choi YK, Liangpunsakul S, Huh YH, Kwon TH, Park KG, Harris RA, Park KS, Rhee HW, Lee IK. PDK4 Augments ER-mitochondria contact to dampen skeletal muscle insulin signaling during obesity. Diabetes. 2019;68(3):571–86. https://doi.org/10.2337/db18-0363.CrossRefPubMed Thoudam T, Ha CM, Leem J, Chanda D, Park JS, Kim HJ, Jeon JH, Choi YK, Liangpunsakul S, Huh YH, Kwon TH, Park KG, Harris RA, Park KS, Rhee HW, Lee IK. PDK4 Augments ER-mitochondria contact to dampen skeletal muscle insulin signaling during obesity. Diabetes. 2019;68(3):571–86. https://​doi.​org/​10.​2337/​db18-0363.CrossRefPubMed
19.
go back to reference Vasheghani F, Zhang Y, Li Y, Blati M, Fahmi H, Lussier B, Roughley P, Lagares D, Endisha H, Saffar B, Lajeunesse D, Marshall W, Rampersaud Y, Mahomed N, Gandhi R, Pelletier J, Martel-Pelletier J, Kapoor MJAotrd. PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage. Ann Rheumatic Dis. 2015;74(3):569–78. https://doi.org/10.1136/annrheumdis-2014-205743.CrossRef Vasheghani F, Zhang Y, Li Y, Blati M, Fahmi H, Lussier B, Roughley P, Lagares D, Endisha H, Saffar B, Lajeunesse D, Marshall W, Rampersaud Y, Mahomed N, Gandhi R, Pelletier J, Martel-Pelletier J, Kapoor MJAotrd. PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage. Ann Rheumatic Dis. 2015;74(3):569–78. https://​doi.​org/​10.​1136/​annrheumdis-2014-205743.CrossRef
25.
go back to reference Muñoz-Valle J, Oregón-Romero E, Rangel-Villalobos H, Martínez-Bonilla G, Castañeda-Saucedo E, Salgado-Goytia L, Leyva-Vázquez M, Illades-Aguiar B, Alarcón-Romero LC, Espinoza-Rojo M, Parra-Rojas I. High expression of TNF alpha is associated with -308 and -238 TNF alpha polymorphisms in knee osteoarthritis. Clin Exp Med. 2014;14(1):61–7. https://doi.org/10.1007/s10238-012-0216-3.CrossRefPubMed Muñoz-Valle J, Oregón-Romero E, Rangel-Villalobos H, Martínez-Bonilla G, Castañeda-Saucedo E, Salgado-Goytia L, Leyva-Vázquez M, Illades-Aguiar B, Alarcón-Romero LC, Espinoza-Rojo M, Parra-Rojas I. High expression of TNF alpha is associated with -308 and -238 TNF alpha polymorphisms in knee osteoarthritis. Clin Exp Med. 2014;14(1):61–7. https://​doi.​org/​10.​1007/​s10238-012-0216-3.CrossRefPubMed
26.
31.
go back to reference Steiner RD, Basel D (1993) COL1A1/2 Osteogenesis Imperfecta. In: Adam MP, Feldman J, Mirzaa GM et al. (eds) GeneReviews((R)). Seattle (WA) Steiner RD, Basel D (1993) COL1A1/2 Osteogenesis Imperfecta. In: Adam MP, Feldman J, Mirzaa GM et al. (eds) GeneReviews((R)). Seattle (WA)
34.
49.
52.
go back to reference Sabatini M, Bardiot A, Lesur C, Moulharat N, Thomas M, Richard I, Fradin A. Effects of agonists of peroxisome proliferator-activated receptor gamma on proteoglycan degradation and matrix metalloproteinase production in rat cartilage in vitro. Osteoarthr Cartil. 2002;10(9):673–9. https://doi.org/10.1053/joca.2002.0827.CrossRef Sabatini M, Bardiot A, Lesur C, Moulharat N, Thomas M, Richard I, Fradin A. Effects of agonists of peroxisome proliferator-activated receptor gamma on proteoglycan degradation and matrix metalloproteinase production in rat cartilage in vitro. Osteoarthr Cartil. 2002;10(9):673–9. https://​doi.​org/​10.​1053/​joca.​2002.​0827.CrossRef
55.
go back to reference Sugden MC, Bulmer K, Augustine D, Holness MJ. Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion. Diabetes. 2001;50(12):2729–36. https://doi.org/10.2337/diabetes.50.12.2729.CrossRefPubMed Sugden MC, Bulmer K, Augustine D, Holness MJ. Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion. Diabetes. 2001;50(12):2729–36. https://​doi.​org/​10.​2337/​diabetes.​50.​12.​2729.CrossRefPubMed
Metadata
Title
PDK4 inhibits osteoarthritis progression by activating the PPAR pathway
Authors
Zhengnan Li
Lifeng Xie
Hui Zeng
Yaohong Wu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Journal of Orthopaedic Surgery and Research / Issue 1/2024
Electronic ISSN: 1749-799X
DOI
https://doi.org/10.1186/s13018-024-04583-5

Other articles of this Issue 1/2024

Journal of Orthopaedic Surgery and Research 1/2024 Go to the issue